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4.1  HIV Prevalence 2016
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HIV Prevalence Technical Notes 13
HIV Services Technical Notes 15
The Centers for Disease Control and Prevention (CDC) estimates that at the end of 2016, 1.14 million people in the United States
were living with HIV, including an estimated 162,500 individuals who were not yet diagnosed.  HIV prevention, diagnosis, and
treatment are a national public health priority. In 2019, the US Department of Health and Human Services launched Ending the
HIV Epidemic: A Plan for America, a cross-agency initiative to leverage scientific advances in HIV prevention, diagnosis,
treatment, and outbreak response.  The initiative aims to decrease HIV infections in the United States by 75 percent by 2025
and 90 percent by 2030. The first phase of the initiative focuses on areas of the United States that are most impacted by HIV,
including 48 counties, Washington DC; San Juan, Puerto Rico; and seven states the CDC has identified as having a substantial
rural HIV burden (Alabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma, and South Carolina).
This chart book provides an update to the South Carolina Rural Health Research Center’s 2013 report HIV/AIDS in Rural
America: Prevalence and Service Availability, which examined rural-urban HIV prevalence in 2008 and availability of Ryan White
medical providers. The research found that HIV prevalence for rural counties was highest in southern states; but within these
states, rates were higher in urban counties than rural. The report also found lower availability of Ryan White providers in rural




County-level rurality was defined using the National Center
for Health Statistics (NCHS) 2013 Urban-Rural Classification
Scheme for Counties, which categorizes counties into six
mutually exclusive groups: large central metro (U1), large
fringe metro (U2), medium metro (U3), small metro (U4),
micropolitan (R1), and noncore (R2). 
Throughout this chartbook, analyses are presented across
the NCHS six-level rurality classification scheme, and by an
aggregated two-level urban/rural variable.




1. What is the prevalence of HIV by rurality of county and US Census region?
2. What is the availability of HIV prevention, testing, and treatment services by rurality of county and US Census region?
The primary research questions investigated in this chartbook are:
This chart book examines 2016 HIV prevalence and the availability of HIV prevention, testing, and treatment services
across the rural-urban continuum and by US Census region. Publicly available county-level HIV prevalence data from the
CDC and state-produced HIV surveillance reports were used to estimate HIV prevalence across the rural-urban continuum. 
HIV prevalence data include all diagnoses of HIV infection, with or without a stage 3 (AIDS) diagnosis. Geocoded data on
organizations that provide prevention, testing, and treatment services related to HIV were obtained from the National





Data on state-level HIV prevalence in 2016 from the CDC’s AtlasPlus database show variation across US states and Census
regions. HIV prevalence ranges from 60 per 100,000 population in North Dakota to 2,434 per 100,000 population in
Washington, DC. Four of the five jurisdictions with the highest HIV prevalence in 2016 are located in the southern Census
region. Across the US Census regions, HIV prevalence is highest in the Northeast (458 per 100,000 population) and lowest
in the Midwest (205 per 100,000 population).
Prevalence per 100,000





Figure 1: Map of HIV Prevalence, by State
Figure 2: HIV Prevalence, by Census Region
SECTION 1: HIV Prevalence 2016
















Figure 4: Percentage of Counties with Suppressed
HIV Prevalence Data in AtlasPlus, by Census Region
Figure 3: Percentage of Counties with Suppressed 
HIV Prevalence Data in AtlasPlus, by Rurality
County-level HIV prevalence data were suppressed in AtlasPlus for 593 counties across 37 states (20 percent of counties in
the US) in 2016, in accordance with data sharing agreements. In many cases, data were suppressed because there were
fewer than five identified persons living with HIV in the county. Compared with urban counties, a greater proportion of
rural counties had HIV data suppressed (26 percent of rural counties compared with 6 percent of urban counties). Across
the US Census regions, the West and Midwest had the largest proportion of counties with suppressed HIV prevalence
data in AtlasPlus.
Data Availability
SECTION 1: HIV Prevalence 2016
1.2  County-Level HIV Prevalence
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We used data from the CDC’s AtlasPlus database to estimate HIV prevalence by county and county-level rurality.
For counties with suppressed or incomplete AtlasPlus HIV prevalence data, we used state HIV surveillance reports
to fill in missing county-level data. See technical notes and the Appendix for additional information.
Methods
Figure 6: Map of HIV Prevalence, by Rurality
Prevalence per 100,000









HIV prevalence was higher among urban counties (399 per 100,000) than rural counties (149 per 100,000), with prevalence
decreasing with increasing rurality. Rural and urban counties in the top tertile of HIV prevalence (above 173 per 100,000)
were primarily located in the South.
Estimated HIV Prevalence, by County
Figure 5:  HIV Prevalence, by Rurality
SECTION 1: HIV Prevalence 2016
1.2  County-Level HIV Prevalence
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The five states with the highest rural HIV prevalence were located in the South (Florida, South Carolina, Georgia,
Louisiana, and Mississippi). Urban HIV prevalence was higher than rural county-level HIV prevalence in all but two states
(South Carolina and Hawaii).
Rural and Urban HIV Prevalence, by State
SECTION 1: HIV Prevalence 2016
1.2  County-Level HIV Prevalence
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Figure 7: Rural and Urban HIV Prevalence, Ordered by Rural HIV Prevalence
*Figure excludes Washington, DC, which was classified as an urban area and had an HIV prevalence of 2,445 per 100,000 population.
Urban
Rural
The 16 HIV-related services included in this analysis were: conventional blood HIV testing, rapid blood HIV testing,
conventional oral HIV testing, rapid oral HIV testing; testing services for chlamydia, gonorrhea, syphilis, herpes, and HCV; HIV
prevention education, hepatitis prevention education, Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP),
PrEP navigation and support services, HIV medical treatment, and hepatitis C virus (HCV) treatment and care. Counties
were categorized as having one or more HIV-related service available if any of the 16 services were offered in that county by
an organization listed in the National Prevention Information Network Database.
HIV-Related Service Availability
KEY TAKEAWAYS:
Compared with urban counties, a smaller proportion of rural counties had organizations in the county that
provided one or more HIV-related service.
Compared with urban counties in the same Census region, a smaller proportion of rural counties in the Midwest,
South, and West had organizations in the county that provided one or more HIV-related service.
SECTION 2: HIV Services 2019
2.1  County-Level Data:
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Figure 10: Map of Counties with One or More HIV-Related Service Available
. : Availability of HIV-Related Services Listed in the NPIN Database
Figure 8: Percentage of Counties with One or More
HIV-Related Service Available, by Rurality
Figure 9: Percentage of Counties with One or More HIV-
Related Service Available, by Rurality and Census Region
Availability of one or more
HIV-related service
Rural, services not present
Urban, services not present
Rural, services present
Urban, services present
Figure 13: Map of Counties with One or More HIV Service Available
The nine HIV services included in this analysis were: HIV/AIDS prevention education, Pre-Exposure Prophylaxis (PrEP),
Post-Exposure Prophylaxis (PEP), HIV/AIDS medical services, PrEP navigation, conventional blood HIV testing,
conventional oral HIV testing, rapid blood HIV testing, and rapid oral HIV testing. Counties were categorized as having one
or more HIV service available if any of the nine services were offered in that county by an organization listed in the
National Prevention Information Network Database.
HIV Service Availability
SECTION 2: HIV Services 2019
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KEY TAKEAWAYS:
Compared with urban counties, a smaller proportion of rural counties had organizations in the county that
provided one or more HIV service.
Compared with urban counties in the same Census region, a smaller proportion of rural counties in the Midwest,
South, and West had organizations in the county that provided one or more HIV service.
2.1  County-Level Data: Availability of HIV-Related Services Listed in the NPIN Database
Figure 11: Percentage of Counties with One or More
HIV Service Available, by Rurality
Figure 12: Percentage of Counties with One or More HIV
Service Available, by Rurality and Census Region
Availability of one or
more HIV service
Rural, services not present




Compared with urban counties, a smaller proportion of rural counties had organizations that provided HIV
testing services.
Compared with urban counties in that Census region, a smaller proportion of rural counties had an organization
that provided HIV testing services in the Midwest. South, and West.
Figure 16: Map of Availability of HIV Testing Services
HIV Testing Services
The CDC and the US Preventive Services Task Force recommend screening adolescents, adults, and all pregnant women
for HIV.     HIV testing services include conventional blood testing, conventional oral testing, rapid blood testing, and rapid
oral testing.
5,6
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7
2.1  County-Level Data: Availability of HIV-Related Services Listed in the NPIN Database
Figure 14: Percentage of Counties with HIV Testing
Services, by Rurality
Figure 15: Percentage of Counties with HIV Testing
Services, by Rurality and Census Region
Availability of HIV testing services
Rural, services not present
Urban, services not present
Rural, services present
Urban, services present
Figure 19: Map of Availability of Rapid Testing Services
HIV Rapid Testing Services
Rapid tests have a quicker run time than conventional HIV tests, can be processed outside a laboratory, and allow
individuals to receive test results at the point of care.   Rapid tests using a fingerstick or oral fluid may be used in
nonclinical community settings that are not equipped to conduct venipuncture.8
7
SECTION 2: HIV Services 2019
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2.1  County-Level Data: Availability of HIV-Related Services Listed in the NPIN Database
KEY TAKEAWAYS:
Across all Census regions and rural classifications, a smaller proportion of rural counties had an organization that
provided HIV rapid testing services compared with urban counties.
Figure 17: Percentage of Counties with HIV Rapid
Testing Service Availability, by Rurality
Figure 18: Percentage of Counties with HIV Rapid Testing
Service Availability, by Rurality and Census Region
Availability of HIV rapid 
testing services
Rural, services not present
Urban, services not present
Rural, services present
Urban, services present
HIV/AIDS prevention education aims to reduce HIV transmission by educating individuals on actions they can take
to protect themselves, how to engage in less risky behaviors, how to use risk reduction tools, and how to access HIV
preventive services in health care settings.
HIV Prevention Education
SECTION 2: HIV Services 2019
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Figure 22: Map of Availability of HIV Prevention Education
KEY TAKEAWAYS:
Compared with urban counties, a smaller proportion of rural counties had an organization that provided 
HIV prevention education.
Compared with urban counties in the same Census region, a smaller proportion of rural counties in the Midwest,
South, and West had an organization providing HIV prevention education.
2.1  County-Level Data: Availability of HIV-Related Services Listed in the NPIN Database
Figure 21: Percentage of Counties with HIV Prevention
Education Available, by Rurality and Census Region
Figure 20: Percentage of Counties with HIV
Prevention Education Available, by Rurality
Availability of HIV/AIDS
prevention education 
Rural, services not present




Compared with urban counties, a smaller proportion of rural counties had an organization in that county that
provided PrEP services.
Compared with urban counties in that Census region, a smaller proportion of rural counties had an organization
that provided PrEP services.
Figure 25: Map of PrEP Service Availability
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PrEP Service Availability
Pre-Exposure Prophylaxis (PrEP) is the use of daily medication to lower the chance of HIV infection. The CDC and the US
Preventive Services Task Force recommend providing PrEP to individuals who are not infected with HIV and are at high
risk of acquiring HIV from sex or injection drug use.   9,10
SECTION 2: HIV Services 2019
2.1  County-Level Data: Availability of HIV-Related Services Listed in the NPIN Database
Figure 23: Percentage of Counties with PrEP
Services Available, by Rurality
Figure 24: Percentage of Counties with PrEP
Services Available, by Rurality and Census Region
Availability of PrEP services
Rural, services not present





HIV/AIDS medical treatment services were available in a smaller proportion of rural counties compared with
urban counties.
In each Census region, a smaller proportion of rural counties had an organization providing HIV/AIDS medical
services compared with urban counties.
HIV/AIDS medical treatment is the provision of clinical services to patients diagnosed with HIV. The services are designed
to reduce the level of HIV in the body, keep the immune system as healthy as possible, and decrease complications that
may develop.
HIV/AIDS Medical Treatment Service Availability
SECTION 2: HIV Services 2019
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Figure 28: Map of HIV/AIDS Medical Treatment Service Availability
2.1  County-Level Data: Availability of HIV-Related Services Listed in the NPIN Database
Figure 26: Percentage of Counties with HIV/AIDS
Medical Treatment Service Available, by Rurality
Figure 27: Percentage of Counties with HIV/AIDS Medical
Treatment Service Available, by Rurality and Census Region
Availability of HIV/AIDS
medical treatment
Rural, services not present




SECTION 3: Conclusion 12
The figures in this chartbook show geographic differences in HIV prevalence and the availability of HIV-related services across
the rural-urban continuum and Census regions in the United States. HIV prevalence is higher in urban counties than rural
counties (399 per 100,000 compared with 149 per 100,000, respectively), with prevalence decreasing with increasing level of
rurality. HIV prevalence in urban counties is higher than HIV prevalence in rural counties in all but two states (South Carolina
and Hawaii). The Northeast has the highest HIV prevalence (485 per 100,000) followed by the South (429 per 100,000), West
(302 per 100,000), and Midwest (205 per 100,000).
Analyses of the availability of HIV-related services show that compared with urban counties, a smaller proportion of rural
counties have organizations that provided HIV prevention, testing, and treatment services. For example, organizations that
provide HIV testing services are located in 88 percent of urban counties compared with 69 percent of rural counties, and rapid
HIV testing services are available in 58 percent of urban counties compared with 26 percent of rural counties. In the Midwest,
Southern, and Western Census regions, the availability of HIV-related services in rural counties was lower for each service
examined compared with urban counties in the same Census region. In the Northeast, however, rural-urban differences in the
availability of services were not found for HIV prevention education, HIV testing, HIV services, and HIV-related services. These
analyses of HIV service availability align with three pillars of the Ending the HIV Epidemic initiative: prevention, diagnosis, and
treatment. These findings may inform the scale up of HIV-related public health efforts in the seven rural states identified by the
Initiative as having a substantial rural HIV burden as well as rural counties identified in this study as falling into the upper tertile
of HIV prevalence rates. Limited availability of testing, education, and PEP/PrEP in some rural areas of the country may
challenge efforts to end the HIV epidemic.
One limitation of the HIV/AIDS in Rural America report on which this study is based is the lack of county-level HIV prevalence
data for 2008 for 22 states. A contribution of the present analysis is the estimation of HIV case counts and prevalence rates for
every county in the country. Both this study and HIV/AIDS in Rural America found that HIV prevalence declined with rurality.
However, the findings presented in this chart book differ from those of the HIV/AIDS in Rural America in several ways. While the
analysis of 2008 data found that the South had the highest overall HIV prevalence rate, the present analysis of 2016 data found
that the Northeast has the highest HIV prevalence rate. HIV/AIDS in Rural America identified South Carolina, Mississippi, and
Louisiana as the states with the highest rural HIV prevalence in 2008. The present analysis identified Florida, South Carolina,
and Georgia as the states with the highest rural HIV prevalence in 2016. Differences in the findings of the two reports may be
due to the differences in data availability and/or changes in HIV prevalence between 2008 and 2016.
The present analysis and HIV/AIDS in Rural America used different data sources to assess the availability of HIV-related
services. While the South Carolina Rural Health Research Center examined the presence of Ryan White medical providers, the
current analysis used data from the NPIN to examine the presence of organizations that provide HIV-related services,
regardless of participation in the Ryan White Program. Both studies found that a smaller proportion of rural counties have HIV-
related services located in the county.
The present analysis and HIV/AIDS in Rural America use different data sources to assess the availability of HIV-related services.
While the South Carolina Rural Health Research Center examined the presence of Ryan White medical providers, the current
analysis used data from the NPIN to examine the presence of organizations that provide HIV-related services, regardless of
participation in the Ryan White Program. Both studies found that a smaller proportion of rural counties have HIV-related
services located in the county. A limitation of the analyses presented in this chartbook is the use of counties as the unit of
analysis, which may mask heterogeneity of HIV prevalence and access to services within counties.
Studies of HIV prevalence often neglect to analyze and present data by rurality. The findings of this study may help inform
policies that augment rural HIV prevention, diagnosis, treatment, and outbreak response efforts.
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SECTION 4: Technical Notes
The primary source of data for 2016 HIV prevalence estimates was the CDC’s online AtlasPlus database, which includes
surveillance data for HIV, viral hepatitis, tuberculosis, and sexually transmitted diseases.   The HIV prevalence data in AtlasPlus
are from the National HIV Surveillance System, which aggregates data from all 50 states, the District of Columbia, and six US
dependent areas. The AtlasPlus data used in the present analyses include all persons aged 13 and older living with diagnosed
HIV or AIDS at the end of 2016. In order to ensure accurate HIV case counts and prevalence rates, the CDC accounts for deaths
among persons living with HIV by linking the state-provided HIV surveillance data to the National Death Index. The CDC also
de-duplicates data for individuals living with HIV who are reported by multiple states based on their most recent known
address as of December 31, 2016.
AtlasPlus HIV prevalence data have several limitations. Data do not include individuals with HIV who have not been tested or
those who have received anonymous testing services. The Atlas data also represent minimum HIV prevalence estimates due
to incomplete information on a person’s clinical, vital, and residence status, which varies across states. CDC estimates that
completeness of HIV reporting is at more than 80 percent. Additionally, the CDC suppresses county-level data from the online
AtlasPlus database if the population denominator is less than 100, if total case counts are between one and four, or if
suppression is required per agreements between the CDC and state/local HIV surveillance programs.
We accessed HIV prevalence data from AtlasPlus on December 11, 2019. For 14 states, AtlasPlus had county-level prevalence
estimates for every county in the state (Alabama, Arizona, Connecticut, Delaware, Washington DC, Florida, Massachusetts,
Maryland, Maine, New Hampshire, New Jersey, Rhode Island, South Carolina, and Vermont). In the remaining 36 states and the
District of Columbia, the CDC suppressed county-level data with varying frequency across states (see Appendix A). In total,
data were suppressed for 593 counties (19.9 percent of counties in the US).
In order to fill in missing county-level HIV case counts and prevalence rates, and to account for incomplete reporting in the
AtlasPlus database, we searched each state’s health department website for 2016 HIV surveillance reports that included
information on sub-state level case counts and/or prevalence rates. Our goal was to obtain county-level estimates for each
state that summed to within +/-10% of the total AtlasPlus HIV case counts for that state in 2016. We selected the AtlasPlus HIV
case counts for each state as the comparison because these cases have been de-duplicated and do not include persons who
have died (as described above). We used Statistical Analysis System (SAS)   software as our primary tool for data entry and
analysis.
We used five different methods to calculate county-level HIV prevalence estimates for the chartbook (see Appendix A):
Level 1: AtlasPlus data only (n=13 jurisdictions)
For each state and the District of Columbia, we compared the AtlasPlus state case total for HIV to the sum of the AltasPlus
county-level HIV case data within that state. In addition to discrepancies due to county-level data suppression, discrepancies
between state-level case counts and the sum of county case counts occurred when case report forms received by the CDC
had incomplete county of residence information. When the county information was not available, the CDC assigned the case
to the state but was not able to assign it to a particular county within that state. Among the 14 states that had HIV prevalence
data for every county within the state, 13 states were within the +/- 10% discrepancy goal. Therefore, for those 13 states we
used AtlasPlus provided county-level case counts for all analyses of HIV county-level prevalence (Alabama, Arizona,





4.1  HIV Prevalence Technical Notes
Level 2: AtlasPlus data supplemented with data from state surveillance reports and imputations of 1 for suppressed
county-level data (n=31 states)
For the remaining states, we supplemented AtlasPlus county-level data with HIV prevalence data from state surveillance
reports and imputed values of 1 for counties with data that were suppressed in AtlasPlus, following an approach used by the
South Carolina Rural Health Research Center in HIV/AIDS in Rural America: Prevalence and Service. This analysis was possible
for 36 states (Rhode Island had no missing county level data in AtlasPlus and Alaska had all counties missing data in AtlasPlus).
We found 31 states where the discrepancy using this approach was within the +/-10% discrepancy goal. Therefore, for these 31
states we used Level 2 case counts for all analyses of HIV county-level prevalence (Arkansas, California, Colorado, Hawaii,
Iowa, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North
Dakota, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, South Dakota, Tennessee, Texas, Utah, Washington,
Wisconsin, West Virginia, and Wyoming).
Level 3: State surveillance reports and imputations of 1 for suppressed county-level data (n=4 states)
For four of the remaining states for which we had state-provided HIV prevalence data for each county, we used only state-
provided data to calculate county-level data. We found three states where the discrepancy using this approach was within the
+/-10% discrepancy goal (Georgia, Pennsylvania, and Rhode Island). For the remaining state, Virginia, the discrepancy was
above 10% (13%), but we were unable to improve on this estimate using other methodology, so we used Level 3 case counts for
all analyses of county-level HIV prevalence for Virginia.
Level 4: AtlasPlus data supplemented with data from state surveillance reports using district-level data (n=1 state)
Three remaining states provided HIV case counts at the public health district (also called regional) level. We distributed
district-level cases to counties within the district based on each county’s share of the district’s population. We found one state
where the discrepancy using this approach was within the +/-10% discrepancy goal (Alaska), and therefore used Level 4 case
counts for all analyses of HIV county-level prevalence for Alaska.
Level 5: State surveillance reports using district-level data (n=2 states)
For the two remaining states we used county-level case counts derived from district-level case counts in lieu of case county
counts from AtlasPlus. In both states this approach brought the discrepancy with the AtlasPlus state-level case count within
the +/- 10% discrepancy goal (Idaho, and Nebraska). For Idaho, we used the state-provided case total as our comparison
instead of the AtlasPlus state case total, due to a discrepancy between the AtlasPlus state case total and the state-provided
surveillance data.
SECTION 4: Technical Notes
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4.1  HIV Prevalence Technical Notes (continued)
In October 2019, we obtained geocoded data from the CDC National Prevention Information Network’s (NPIN) Organizations
Database for 11,813 organizations that provided as least one of 16 services   related to HIV/AIDS, viral hepatitis, and sexually
transmitted diseases (STDs). We linked the geocoded data to the 2013 National Center for Health Statistics 6-level urban-rural
classification scheme to categorize organizations as located in urban (levels 1-4) or rural (levels 5-6) counties. We also used the
geocoded data to determine the U.S. Census region in which organizations were located.
NPIN’s Organizations Database, maintained by NPIN staff since 1987, contains information about organizations that provide
services and resources related to HIV/AIDS, viral hepatitis, STDs, and/or tuberculosis. To be included in the database an
organization must focus their services on HIV/AIDS, viral hepatitis, STDs or tuberculosis or offer specific programs focused on
one or more of these diseases. Organizations include AIDS service organizations, clinics, hospitals, public health departments,
social service organizations, and others. Private physicians and practices are not included in the Organizations Database
because they generally do not focus on HIV/AIDs, viral hepatitis, STDs, or tuberculosis, and often provide services for
established patients only. However, commercial clinics are included in the Database if they have a partnership with a state or
local health department to offer these services or are located in an underserved or rural area with limited service options.
NPIN staff identify these organizations’ services using a variety of strategies including searching the internet and reviewing the
websites of organizations that are already in the database. When a new organization is identified as providing relevant services,
NPIN staff collect information about the organization and the services they offer by reviewing their website and/or contacting
the organization by phone. Organizations can also add or update information about their organization through the NPIN and
Get Tested websites. Approximately 15 percent of organizations in the database are added through this self-reporting
mechanism. The data for all of the organizations included in the database are verified annually. In addition to annual updates,
ad hoc updates are made when NPIN staff learn that information about an organization has changed (for example, the name of
the organization changes or a service is discontinued). The NPIN Organizations Database has been used by researchers to
examine access to HIV/AIDS care and treatment         and identify organizations eligible to participate in surveys about
provision of care.
Inclusion of an organization in the NPIN's Organizations Database is not a recommendation or endorsement by the Centers for
Disease Control and Prevention or the CDC National Prevention Information Network.
SECTION 4: Technical Notes
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The 16 services are HIV/AIDS prevention education, Hepatitis prevention education, Pre-exposure prophylaxis, Post-
exposure prophylaxis, HIV/AIDS medical treatment, Hepatitis C treatment and care, PrEP navigation and support services,
Chlamydia testing, Gonorrhea testing, Syphilis testing, herpes testing, Conventional blood HIV testing, Conventional oral
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County-level HIV prevalence estimation methodology for 50 states and District of Columbia (N=51 jurisdictions) in 2016. Green cells indicate methodology selected
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